| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:2660.)
© 2003 American Heart Association, Inc.
Brief Rapid Communications |
From the Cardiovascular Research Foundation (G.S.M.), New York, NY; and Cardiovascular Research Institute (V.MS, N.J.W.), Washington Hospital Center, Washington, DC.
Correspondence to Neil J. Weissman, MD, Washington Hospital Center, 110 Irving St, NW Suite 4B-1, Washington DC 20010. E-mail neil.j.weissman{at}medstar.net
| Abstract |
|---|
|
|
|---|
Methods and Results Corresponding image slices on postimplantation and follow-up IVUS studies of 11 malapposed stents were identified and electronically rotated until they were aligned. The geometric center of the stent was identified, and the angle of late malapposition measured. Radii were drawn from this center through the transition points between complete apposition and LSM. These two circumferences were divided into equal arcs, and radii were drawn to the external elastic membrane (EEM). Measurements included EEM radius and circumference, plaque and media (P&M=EEM minus stent radius) thickness and area, and stent-intima separation. Mean baseline EEM radius and P&M thickness were similar in apposed and malapposed circumferences. At follow-up, mean EEM radius increase within the malapposed circumference (0.57±0.34 mm) was larger than within the apposed circumference (0.16±0.18 mm; P=0.0004).
EEM for each malapposed radius was greater than for each apposed radius (P<0.05 for all comparisons). Stent-intima separation correlated with EEM radius increase within the malapposed circumference (r=0.83, P=0.0013). At follow-up, the mean P&M thickness decreased in the malapposed circumference (-0.31±0.22 mm; P<0.0001). However, the decrease in P&M thickness in the malapposed circumference occurred because the same P&M area was distributed over a larger circumference (4.1±1.6 mm to 5.4±3.0 mm; P=0.05), the result of positive remodeling.
Conclusion The main cause of LSM is a regional increase in EEM (regional positive remodeling).
Key Words: stents drugs restenosis imaging
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
1 stent strut from the intima, not overlapping a side-branch, with evidence of blood flow behind the strut, where postimplantation IVUS revealed no evidence of blood speckling behind any strut.
IVUS Imaging and Analysis
IVUS imaging was performed after intracoronary administration of 0.1 to 0.2 mg nitroglycerin using motorized transducer pullback and a commercially available scanner (SCIMED). The imaging catheter was advanced 10 mm distal to the stent, and the transducer was withdrawn at 0.5 mm/s back to the guiding catheter. All studies were recorded on 0.5-inch high-resolution s-VHS videotape for subsequent analysis.
Quantitative IVUS analysis was performed using computerized planimetry (Tape Measure, Indec Systems). The follow-up study was reviewed first to select the image slice with the largest LSM area. Then, the postintervention study was reviewed to identify the corresponding image slice; this was facilitated by motorized transducer pullback because the distance from the stent edge could be measured in both studies. Finally, postintervention and follow-up image slices were rotated electronically so that patterns of stent struts and perivessel landmarks were aligned.5,6
The LSM image slice was analyzed first. (1) The geometric stent center was identified, and the angle of LSM measured with an electronic protractor. (2) Radii were drawn from this center through the two transition points between circumferences of complete apposition and LSM. (3) These two circumferences were divided into equal arcs, and 8 additional radii were drawn to the EEM, three through the apposed arc and five through the malapposed arc (Figure 1). (4) Radial distances were measured from the stent center to the stent, intima, and EEM. (5) Plaque and media (P&M) thickness was calculated as EEM minus stent radius. (6) Separation of LSM was calculated as intimal minus stent radius. (7) The P&M areas and EEM circumferences in apposed and malapposed segments were measured. These same measurements were performed on postimplantation images.
|
Statistics
Statistical analysis was performed using StatView 5.0 (SAS Institute). Quantitative data are presented as mean±1SD and compared using paired Students t test, correlation coefficient, and analysis of variance for repeated measures (with post hoc analysis using Fishers protected least significant difference).
| Results |
|---|
|
|
|---|
Overall, there was a 0.37±0.24-mm increase in EEM radius (2.4±0.3 to 2.8±0.4 mm; P=0.0005), whereas there was no change in P&M thickness (0.8±0.2 to 0.7±0.2 mm; P=0.2). This represented a 15±15 (2% to 33%) increase in EEM radius.
The Table shows index and follow-up IVUS measurements according to the 10 predefined radii. Mean baseline EEM radius and P&M thickness were similar in apposed and malapposed circumferences. At follow-up, there was a consistent increase in EEM of all malapposed radii, but not of all fully apposed radii. The increase in mean EEM radius within the malapposed circumference (0.57±0.34 mm) was larger than within the apposed circumference (0.16±0.18 mm; P=0.0004). This increase averaged 6±8% (0% to 21%) within the apposed circumference versus 24±15% (2% to 56%) within the malapposed circumference. Stent-intima separation correlated with
EEM radius within the malapposed circumference (r=0.83, P=0.0013).
|
At follow-up, mean P&M thickness increased in the apposed circumference (0.18±0.16 mm) and decreased in the malapposed circumference (-0.31±0.22 mm; P<0.0001). However, there was no actual decrease in plaque mass behind the malapposed part of the stent; P&M area measured 1.9±0.9 mm2 at implantation and 2.3±1.4 mm2 at follow-up (P=0.4). The decrease in P&M thickness occurred because the same P&M was distributed over a larger circumference (4.1±1.6 mm to 5.4±3.0 mm; P=0.05), the result of positive remodeling. Stent-intima separation did not correlate with P&M thickness decrease (P=0.3). In the fully apposed circumference, there was an increase in P&M area from 7.2±2.6 mm2 to 9.8±2.9 mm2; P=0.0003).
Figure 2 shows the distance stent-intima separation (measure of LSM) and changes in EEM radius and P&M thickness for the 10 prespecified radii.
EEM radius and
P&M thickness were similar for all prespecified radii within the apposed circumference as well as within the malapposed circumference. However,
EEM for each malapposed radius was greater than for each apposed radius, and
P&M thickness for each malapposed radius was significantly different than for each apposed radius (P<0.05 for all comparisons).
|
| Discussion |
|---|
|
|
|---|
Mechanisms of Late Malapposition
In the present analysis, there was no decrease in any of the stent radii eliminating chronic stent recoil as a finding, but allowing the geometric center of the stent to be used as a constant point of reference. In the current analysis, there was an increase in EEM radius (positive remodeling) within the region of LSM, but no change in plaque mass; the separation of the intima from the stent correlated with the increase in EEM radius. Therefore, the main mechanism of LSM is regional positive remodeling occurring in the setting of no increase in plaque mass. These regional changes were not well detected when changes in total EEM radius were assessed. IVUS analysis of LSM, as well as other focal arterial phenomena, requires a methodology appropriate to the problem. It may not be appropriate to assess mechanisms of LSM (a focal phenomenon) by measuring changes in total arterial EEM or plaque CSA or volumeeven if these are the "standard" analyses performed in IVUS laboratories. Standard analyses may obscure rather than elucidate the actual mechanism. Similar "regional" methodologies may be useful in understanding remodeling responses to focal, eccentric plaque accumulation in de novo lesion formation.
Using serial IVUS, a number of investigators have reported positive remodeling associated with peri-stent plaque increase after bare-metal stent implantation, presumably reflecting peri-stent intimal hyperplasia.7,8 The present analysis suggests that EEM increase is not necessarily a response to peri-stent intimal hyperplasia, but can occur independently. Positive remodeling without an increase in intimal hyperplasia has been noted after brachytherapy.4,9 The present analysis suggests that this phenomenon can occur in the absence of brachytherapy.
The decrease in P&M thickness (but not mass) behind the malapposed stent struts was secondary to positive remodeling. Thus, plaque "thinning" may occur in the absence of plaque regression. In the current study P&M thickness decreased by 0.31±0.22 mm, whereas P&M area increased from 1.9±0.9 mm2 at implantation to 2.3±1.4 mm2 at follow-up.
Limitations
The number of patients with late malapposition was small. The current findings only apply to tubular-slotted stents. The present findings do not apply to re-stenting of in-stent restenosis lesions. The range of increase in malapposed arc EEM area was wide and <10% in 2/11 patients. There were only 2 IVUS studies per patient; therefore, the time course of remodeling (early or late) cannot be determined.
Conclusions
The main cause of late stent malapposition is a regional increase in EEM (regional positive remodeling) that may not be detected during conventional analyses.
Received March 6, 2003; revision received April 7, 2003; accepted April 17, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R Hoffmann, M-C Morice, J W Moses, P J Fitzgerald, L Mauri, G Breithardt, J Schofer, P W Serruys, H-P Stoll, and M B Leon Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials Heart, March 1, 2008; 94(3): 322 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. van der Hoeven, S.-S. Liem, J. W. Jukema, N. Suraphakdee, H. Putter, J. Dijkstra, D. E. Atsma, M. Bootsma, K. Zeppenfeld, P. V. Oemrawsingh, et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Weissman, S. G. Ellis, E. Grube, K. D. Dawkins, J. D. Greenberg, T. Mann, L. A. Cannon, P. A. Cambier, S. Fernandez, G. S. Mintz, et al. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials Eur. Heart J., July 1, 2007; 28(13): 1574 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Siqueira, A. A. Abizaid, J. d. R. Costa, F. Feres, L. A. Mattos, R. Staico, A. A. Abizaid, L. F. Tanajura, A. Chaves, M. Centemero, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes Eur. Heart J., June 1, 2007; 28(11): 1304 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Mintz What to Do About Late Incomplete Stent Apposition? Circulation, May 8, 2007; 115(18): 2379 - 2381. [Full Text] [PDF] |
||||
![]() |
S. Cook, P. Wenaweser, M. Togni, M. Billinger, C. Morger, C. Seiler, R. Vogel, O. Hess, B. Meier, and S. Windecker Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation Circulation, May 8, 2007; 115(18): 2426 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matsumoto, J. Shite, T. Shinke, H. Otake, Y. Tanino, D. Ogasawara, T. Sawada, O. L. Paredes, K.-i. Hirata, and M. Yokoyama Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur. Heart J., April 2, 2007; 28(8): 961 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Camenzind, P. G. Steg, and W. Wijns A Cause for Concern Circulation, March 20, 2007; 115(11): 1440 - 1455. [Full Text] [PDF] |
||||
![]() |
P. Jimenez-Quevedo, M. Sabate, D. J. Angiolillo, M. A. Costa, F. Alfonso, J. A. Gomez-Hospital, R. Hernandez-Antolin, C. Banuelos, J. Goicolea, F. Fernandez-Aviles, et al. Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients: Three-Dimensional Ultrasound Results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial J. Am. Coll. Cardiol., June 6, 2006; 47(11): 2172 - 2179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Hong, G. S. Mintz, C. W. Lee, D.-W. Park, K.-M. Park, B.-K. Lee, Y.-H. Kim, J.-M. Song, K.-H. Han, D.-H. Kang, et al. Late Stent Malapposition After Drug-Eluting Stent Implantation: An Intravascular Ultrasound Analysis With Long-Term Follow-Up Circulation, January 24, 2006; 113(3): 414 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Aoki, A. Colombo, D. Dudek, A. P. Banning, J. Drzewiecki, K. Zmudka, F. Schiele, M. E. Russell, J. Koglin, P. W. Serruys, et al. Peristent Remodeling and Neointimal Suppression 2 Years After Polymer-Based, Paclitaxel-Eluting Stent Implantation: Insights From Serial Intravascular Ultrasound Analysis in the TAXUS II Study Circulation, December 20, 2005; 112(25): 3876 - 3883. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ako, Y. Morino, Y. Honda, A. Hassan, S. Sonoda, P. G. Yock, M. B. Leon, J. W. Moses, H. N. Bonneau, and P. J. Fitzgerald Late Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation: A Serial Intravascular Ultrasound Analysis J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1002 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Weissman, J. Koglin, D. A. Cox, J. Hermiller, C. O'Shaughnessy, J. T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1201 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanabe, P. W. Serruys, M. Degertekin, E. Grube, G. Guagliumi, W. Urbaszek, J. Bonnier, J.-M. Lablanche, T. Siminiak, J. Nordrehaug, et al. Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents: Insights From the Randomized TAXUS II Trial Circulation, February 22, 2005; 111(7): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-K. Hong, G. S. Mintz, C. W. Lee, Y.-H. Kim, S.-W. Lee, J.-M. Song, K.-H. Han, D.-H. Kang, J.-K. Song, J.-J. Kim, et al. Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent Implantation Circulation, February 24, 2004; 109(7): 881 - 886. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Virmani, G. Guagliumi, A. Farb, G. Musumeci, N. Grieco, T. Motta, L. Mihalcsik, M. Tespili, O. Valsecchi, and F. D. Kolodgie Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? Circulation, February 17, 2004; 109(6): 701 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Degertekin, P. W. Serruys, K. Tanabe, C. H. Lee, J. E. Sousa, A. Colombo, M.-C. Morice, J. M.R. Ligthart, and P. J. de Feyter Long-Term Follow-Up of Incomplete Stent Apposition in Patients Who Received Sirolimus-Eluting Stent for De Novo Coronary Lesions: An Intravascular Ultrasound Analysis Circulation, December 2, 2003; 108(22): 2747 - 2750. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |